AWARDDELIVERY ORDEROther than small business
Delivery order HHSN27100001ALBANY MOLECULAR RESEARCH, INC.
Overview
Award facts
- Net obligations
- $173.71K
- $173,705of $195.03K potential value
- Outlays (paid to date)
- $99.47K
- $99.47K paid of $173.71K obligated$99,474
- Period of performance
- Mar 16, 2018 to Mar 15, 2027
- Ends in 3 months
- Modifications
- 9
- Latest action Aug 12, 2026
- Contract type
- Delivery order
- PIID HHSN27100001
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF TASK ORDER NO. 0001 - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP
Dates and value
- Award date
- Signed on Mar 16, 2018
- Potential end of performance
- Mar 15, 2028
- Current value
- $173,705Base and exercised options
- Potential value (if all options are exercised)
- $195,028
- Parent contract vehicle
- HHSN271201800001I (IDC, single award) — 26 orders recorded under it
Obligations by fiscal year of action
- FY2026: $21,111
- FY2025: $20,906
- FY2024: $20,520
- FY2023: $19,924
- FY2022: $19,343
- FY2020: $18,233
- FY2019: $17,702
- FY2018: $35,966
Total across 8 fiscal years: $173,705
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 12, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationALBANY, NY
UEIELCNZCS8GEA3
CAGE code3D1R9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyALBANY MOLECULAR RESEARCH INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NINDS
- Funded from
- National institute of neurological disorders and stroke (0886)Program activities075-0886Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Albany, New York 12212-5098
- Congressional district (place of performance)
- NY-20As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
Solicitation and notices
- Solicitation ID
- NIHNINDS1701(as reported)
Contract details
- Subcontracting plan
- Individual subcontract planF
- Major program
- Medicinal chemistry support program for therapeutic development (MCSP)
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Mar 16, 2018Base obligation at award: $17,186
- Latest action
- Aug 12, 2026 — Option exercisedModification P00009; obligation change +$21,111
- Latest substantive action
- Aug 12, 2026 — Option exercisedModification P00009; obligation change +$21,111
- Latest funding action
- Sep 19, 2024 — Funding onlyModification P00007; obligation change -$1; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Option exercised8
- Funding only1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $21,111
- Latest action: change in base and all options
- -$20,906
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- National Institutes Of Health7529
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 10
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N95A
- Treasury accounts
- 075-2018/2018-0886-000
- 075-2019/2019-0886-000
- 075-2020/2020-0886-000
- 075-2021/2021-0886-000
- 075-2022/2022-0886-000
- 075-2023/2023-0886-000
Show all 9 accounts
- 075-2024/2024-0886-000
- 075-2025/2025-0886-000
- 075-2026/2026-0886-000
- Object classes
- 25.1: Advisory and assistance services
- 25.2: Other services from non-Federal sources
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression